These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 28709489

  • 21. The cellular composition of induced sputum in chronic obstructive pulmonary disease.
    Peleman RA, Rytilä PH, Kips JC, Joos GF, Pauwels RA.
    Eur Respir J; 1999 Apr; 13(4):839-43. PubMed ID: 10362050
    [Abstract] [Full Text] [Related]

  • 22. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease.
    Papi A, Romagnoli M, Baraldo S, Braccioni F, Guzzinati I, Saetta M, Ciaccia A, Fabbri LM.
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1773-7. PubMed ID: 11069811
    [Abstract] [Full Text] [Related]

  • 23. Effect of short-term NO2 exposure on induced sputum in normal, asthmatic and COPD subjects.
    Vagaggini B, Paggiaro PL, Giannini D, Franco AD, Cianchetti S, Carnevali S, Taccola M, Bacci E, Bancalari L, Dente FL, Giuntini C.
    Eur Respir J; 1996 Sep; 9(9):1852-7. PubMed ID: 8880102
    [Abstract] [Full Text] [Related]

  • 24. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.
    Perng DW, Wu CC, Su KC, Lee YC, Perng RP, Tao CW.
    Lung; 2006 Sep; 184(4):217-22. PubMed ID: 17006748
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
    Franciosi LG, Diamant Z, Banner KH, Zuiker R, Morelli N, Kamerling IM, de Kam ML, Burggraaf J, Cohen AF, Cazzola M, Calzetta L, Singh D, Spina D, Walker MJ, Page CP.
    Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275
    [Abstract] [Full Text] [Related]

  • 26. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
    Górska K, Paplińska-Goryca M, Nejman-Gryz P, Goryca K, Krenke R.
    COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
    [Abstract] [Full Text] [Related]

  • 27. [Safety of sputum induction in interstitial lung disease].
    Sobiecka M, Kuś J.
    Pneumonol Alergol Pol; 2008 Apr; 76(1):11-8. PubMed ID: 18283650
    [Abstract] [Full Text] [Related]

  • 28. Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice.
    D'silva L, Hassan N, Wang HY, Kjarsgaard M, Efthimiadis A, Hargreave FE, Nair P.
    Can Respir J; 2011 Apr; 18(3):144-8. PubMed ID: 21766077
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD).
    Grootendorst DC, Gauw SA, Benschop N, Sterk PJ, Hiemstra PS, Rabe KF.
    Pulm Pharmacol Ther; 2003 Apr; 16(6):341-7. PubMed ID: 14580925
    [Abstract] [Full Text] [Related]

  • 30. [Reproducibility in induced sputum in children with asthma].
    Reining U, Mattes J, Storm van's Gravesande K, Ihorst G, Kühr J.
    Pneumologie; 2000 May; 54(5):185-90. PubMed ID: 10865471
    [Abstract] [Full Text] [Related]

  • 31. Bronchodilator response of advanced lung function parameters depending on COPD severity.
    Jarenbäck L, Eriksson G, Peterson S, Ankerst J, Bjermer L, Tufvesson E.
    Int J Chron Obstruct Pulmon Dis; 2016 May; 11():2939-2950. PubMed ID: 27932874
    [Abstract] [Full Text] [Related]

  • 32. [Asthma-COPD overlap syndrome among patients with stable COPD].
    Nguyen MS, Nguyen Dang D, Schleich F, Manise M, Corhay JL, Louis R.
    Rev Med Liege; 2015 Jan; 70(1):37-43. PubMed ID: 25902605
    [Abstract] [Full Text] [Related]

  • 33. Airway inflammation and cellular stress in noneosinophilic atopic asthma.
    Tsoumakidou M, Papadopouli E, Tzanakis N, Siafakas NM.
    Chest; 2006 May; 129(5):1194-202. PubMed ID: 16685009
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Exhaled nitric oxide correlated with induced sputum findings in COPD.
    Silkoff PE, Martin D, Pak J, Westcott JY, Martin RJ.
    Chest; 2001 Apr; 119(4):1049-55. PubMed ID: 11296168
    [Abstract] [Full Text] [Related]

  • 36. Safety of one method of sputum induction in asthmatic subjects.
    Wong HH, Fahy JV.
    Am J Respir Crit Care Med; 1997 Jul; 156(1):299-303. PubMed ID: 9230765
    [Abstract] [Full Text] [Related]

  • 37. Long-term effects of budesonide on inflammatory status in COPD.
    Boorsma M, Lutter R, van de Pol MA, Out TA, Jansen HM, Jonkers RE.
    COPD; 2008 Apr; 5(2):97-104. PubMed ID: 18415808
    [Abstract] [Full Text] [Related]

  • 38. Inflammatory cell profiles and T-lymphocyte subsets in chronic obstructive pulmonary disease and severe persistent asthma.
    Tsoumakidou M, Tzanakis N, Kyriakou D, Chrysofakis G, Siafakas NM.
    Clin Exp Allergy; 2004 Feb; 34(2):234-40. PubMed ID: 14987303
    [Abstract] [Full Text] [Related]

  • 39. Eosinophilic Airway Inflammation in Patients with Stable Biomass Smoke- versus Tobacco Smoke-Associated Chronic Obstructive Pulmonary Disease.
    Fernandes L, Rane S, Mandrekar S, Mesquita AM.
    J Health Pollut; 2019 Dec; 9(24):191209. PubMed ID: 31893170
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.